Comparative Study of Matrix vs. Product-Specific Cleaning Validation Approaches

Cleaning validation is an essential part of the present Good Manufacturing Practices (cGMP) of the pharmaceutical industry. This comparison paper discusses two main cleaning validation methods: the matrix (worst-case) approach and product-specific approach. The paper assesses the strengths, weaknesses, risk profiles and real-world application of both methodologies through the review of regulatory guidance, industry best practices, and case study findings. The matrix approach, which justifies cleaning according to worst-case scenarios of groups of related products, is highly resource-efficient though it calls for hard scientific justification. The product-specific method offers wholesome validation of every product transition but requires enormous resources. The present study is a framework of the choice of the proper validation strategy depending on the features of the facilities, the complexity of the products portfolio, and the results of the risk assessment. This analysis suggests that a combined strategy, comprising factors of both methodologies with visible residue limits (VRL) as a risk-based instrument, may provide an effective balance between regulatory compliance and operational performance.